Election year trend signals market volatility won’t make a comeback


September may look much calmer than Wall Street anticipates.

According to CFRA’s Sam Stovall, an election year trend going back to the 1940s suggests volatility won’t make a comeback in this month.

“A lot of strategists are saying that as we head into the election, markets are likely to get a lot more volatile,” the firm’s chief investment strategist told CNBC’s “Trading Nation” on Tuesday. “But actually history says the opposite.”

Stovall builds his case in a special chart showing volatility during presidential election years versus non-election years since World War II.

“If you look to the volatility in

Read More

Federal health advisors predict four coronavirus vaccine trials backed by U.S. could fail


Rabbi Shmuel Herzfeld has his arm disinfected by Dr. Chao Wang during a clinical trial for a Coronavirus vaccine at Meridian Clinical Research in Rockville, Maryland on Monday, July 27, 2020. The Coronavirus vaccine was created by the biopharmaceutical company Moderna.

Amanda Andrade-Rhoades | The Washington Post | Getty Images

A top group advising U.S. health officials predicted Tuesday that four late-stage coronavirus vaccine trials backed by the United States could fail to provide positive results.

The National Academies of Sciences, Engineering, and Medicine released a draft report that lays out a federal plan for distributing a coronavirus vaccine in

Read More

GM CEO Mary Barra to meet with Ivanka Trump on Wednesday


White House Senior Adviser Ivanka Trump introduces her father U.S. President Donald Trump to deliver his acceptance speech as the 2020 Republican presidential nominee during the final event of the Republican National Convention on the South Lawn of the White House in Washington, August 27, 2020.

Kevin Lamarque | Reuters

DETROIT – General Motors CEO Mary Barra is scheduled to meet Wednesday with White House adviser Ivanka Trump at the automaker’s design and tech center in suburban Detroit.

Barra will give President Donald Trump’s daughter a tour of GM’s Technical Learning University, which recently completed a $2 million upgrade for

Read More

NIH panel refutes FDA’s claims of the benefits of coronavirus plasma treatment


Convalescent plasma from a recovered coronavirus disease (COVID-19) patient is seen at the Central Seattle Donor Center of Bloodworks Northwest during the outbreak in Seattle, Washington, April 17, 2020.

Lindsey Wasson | Reuters

A panel of experts convened by the National Institutes of Health said Tuesday there is “insufficient data” to show convalescent plasma works against the coronavirus, refuting claims made by President Donald Trump and the head of the Food and Drug Administration.

The panel said it reviewed available data on the treatment and found nothing from “well-controlled, adequately powered randomized clinical trials that demonstrate the efficacy and safety

Read More